Links

Zhejiang LangHua Pharmaceutical Co.,LTD.

SYNthesis med chem

Viva BioInnovator

©Viva Biotech (Shanghai) Ltd. 沪ICP备12042930号   Powerd by 300.cn 

About Us
About Viva
Company Culture
Company History
Management Team
Honors
Services
Gene-to-Protein & Gene-to-Structure
Viva Engine for Lead Discovery
Membrane Protein Targeted Discovery Technology
Medicinal Chemistry
In Vitro Pharmacology
Antibody Discovery Service
Products
Cell Lines
Crystal Structures
GPCR Proteins
Antibody
Protein
News
Company news
Industry news
Careers
Senior Management Recruitment
Chemistry Positions
Biology Positions
Home page
>
Industry News
Totient, a Viva Biotech Portfolio Company, Achieves the Acquisition with AbSci

Totient, a Viva Biotech Portfolio Company, Achieves the Acquisition with AbSci
Just now
Intro Remarks：Complementary technologies combined to enable streamlined design and production of next-generation therapeutic proteins for disease-specific targets.
View details
Anji Pharma Launches Phase 3 Trial for ANJ900

Anji Pharma Launches Phase 3 Trial for ANJ900
1 day ago
To treat type 2 diabetes patients with kidney disease
View details
Viva Biotech Included in the MSCI China Small Index Constituent Stocks

Viva Biotech Included in the MSCI China Small Index Constituent Stocks
2021-06-02 16:02
The cradle for biotech companies from all over the world.
View details
Shanghai EPN and BioMap Reached a Strategic Cooperation

Shanghai EPN and BioMap Reached a Strategic Cooperation
2021-05-11 16:51
To jointly work on the development of autoimmune diseases therapies
View details
TechnoDerma Announced New Progress in Phase I Clinical Trials of TDM-105795 in the U.S.

TechnoDerma Announced New Progress in Phase I Clinical Trials of TDM-105795 in the U.S.
2021-05-11 16:49
It is expected that the phase I clinical dose-climbing trial will be completed in about three months.
View details
Page up
1
2
...
12